4.6 Article

Association Between Prostate-Specific Antigen Screening and Prostate Cancer Mortality Among Non-Hispanic Black and Non-Hispanic White US Veterans

Related references

Note: Only part of the references are listed.
Article Oncology

Evaluating Prostate-Specific Antigen Screening for Young African American Men With Cancer

Edmund M. Qiao et al.

Summary: PSA screening is associated with reduced risk of high PSA levels, high Gleason score, metastatic disease, and prostate cancer-specific mortality in young African American men. However, the retrospective design of this study limits the precise estimation of screening effects, and prospective studies are needed to validate these findings.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)

Review Oncology

Prostate Cancer Racial Disparities: A Systematic Review by the Prostate Cancer Foundation Panel

Brandon A. Mahal et al.

Summary: This study critically synthesizes the available evidence on prostate cancer disparities and emphasizes the importance of racially diverse studies to understand and address these disparities. The findings highlight the need for intervention studies and clinical trials that include Black and other men with prostate cancer to reduce the widening disparities.

EUROPEAN UROLOGY ONCOLOGY (2022)

Article Oncology

The Impact of Intensifying Prostate Cancer Screening in Black Men: A Model-Based Analysis

Yaw A. Nyame et al.

Summary: The study found that intensified PSA screening in Black men is expected to reduce mortality more than that estimated under historical screening. Limiting screening to men younger than 70 years is expected to help reduce overdiagnosis.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Article Oncology

Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation

Kevin H. Kensler et al.

Summary: The frequency of prostate cancer screening varies by race and ethnicity, with a steeper decline in PSA testing among younger non-Hispanic Black men relative to non-Hispanic White men since 2012. The incidence rate ratio for localized prostate cancer modestly increased for non-Hispanic Black men compared to non-Hispanic White men after 2012.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Article Medicine, General & Internal

Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality The CAP Randomized Clinical Trial

Richard M. Martin et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

Review Medicine, General & Internal

Screening for Prostate Cancer US Preventive Services Task Force Recommendation Statement

David C. Grossman et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

Article Medicine, General & Internal

Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials

Alex Tsodikov et al.

ANNALS OF INTERNAL MEDICINE (2017)

Article Urology & Nephrology

Do African-American men need separate prostate cancer screening guidelines?

Divya Shenoy et al.

BMC UROLOGY (2016)

Article Oncology

Explaining racial differences in prostate cancer mortality

Glen B. Taksler et al.

CANCER (2012)